Loading...
Recurrent uterine serous carcinoma with a germline pathogenic BRCA2 variant treated using olaparib: A case report
A germline pathogenic variant in BRCA2 was secondarily found through genomic sequencing of uterine serous carcinoma. Clinical response to olaparib was observed in recurrent uterine serous carcinoma with a germline BRCA2 mutation. Here, we report, for the first time, a long-term clinical response to...
Na minha lista:
| Udgivet i: | Gynecol Oncol Rep |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7152717/ https://ncbi.nlm.nih.gov/pubmed/32300630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2020.100563 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|